Protein-L-isoaspartate O-methyltransferase domain containing 1 pseudogene 1 (PCMTD1P1)

PCMTD1P1 is a processed pseudogene in the human genome corresponding to the protein-L-isoaspartate O-methyltransferase domain containing 1 gene. Pseudogenes are DNA segments resembling functional genes but rendered non-coding by accumulated mutations. Unlike some pseudogenes which show regulatory functions in tumorigenesis (e.g., PTENP1, KRASP1), there is no evidence that PCMTD1P1 encodes a functional protein, nor that it provides regulatory or competing endogenous RNA (ceRNA) activity. It is not targeted by drugs, is not a biomarker, and is not considered a therapeutic target. The submitted target is a pseudogene, not a canonical druggable enzyme, receptor, transporter, or protein complex. It is not a recognized therapeutic target and does not fulfill the criteria for molecular classification relevant for drug discovery or biological pathway analysis. There is no evidence for recognized gene regulation, disease association, or clinical relevance for PCMTD1P1 beyond its annotation as a pseudogene. If further research uncovers regulatory functions, this status could change, but such data is absent in current sources. Pseudogenes are non-functional segments of DNA that resemble functional genes, can sometimes regulate their parent genes but often have no protein-coding potential or direct biological activity. Therefore, PCMTD1P1 should not be considered a therapeutic target, is not drug-interacted, is not involved in recognized biological pathways or clinical biomarkers, and its inclusion as a molecular target is incorrect based on current scientific evidence.

Other names

PCMTD1P1

None